Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Radiotherapy Combined With Targeted Therapy in Asymptomatic NSCLC Brain Metastasis
NCT04193007Phase 2Unknown
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoints: Intracranial Progression-Free Survival up to 2 years and Objective Response Rate. Status: unknown.
Beyond the preview
Go deeper on NCT04193007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04193007.